Abdera Therapeutics

San Diego, United States · Founded 2020 · $142.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$142.0M
Last Round
$32.0M Series AJan 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Abdera Therapeutics is a precision oncology biopharmaceutical company leveraging antibody engineering to design and develop next-generation targeted radiopharmaceuticals for patients with relapsed, refractory, and advanced cancers. The company's platform uses tunable, antibody-based constructs to deliver targeted radiation directly to tumor cells, enabling highly specific cancer cell killing while minimizing damage to surrounding healthy tissue. Founded in 2020 and headquartered in San Diego, California, Abdera debuted with $142 million in financing to advance its pipeline of precision radiopharmaceutical therapies.

Summary

Abdera Therapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $142.0M in total across 2 rounds, most recently a $32.0M Series A round in Jan 2021. Investors include Versant Ventures, Amplitude Ventures and venBIO Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2021
$32.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Abdera Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/abdera-therapeutics"><img src="https://indexed.vc/api/badge/company/abdera-therapeutics" alt="Abdera Therapeutics on Indexed.vc" width="260" height="76" /></a>